Medicine & Life Sciences

1. Multiple Myeloma 100%
2. tasquinimod 52%
3. Myeloid Cells 35%
4. Tumor Microenvironment 34%
5. Neoplasms 31%
6. Acute Myeloid Leukemia 24%
7. venetoclax 23%
8. Adrenergic Agents 22%
9. Cell Survival 21%
10. Propranolol 20%
11. Immunosuppressive Agents 18%
12. Calgranulin B 18%
13. Single-Domain Antibodies 16%
14. Adrenergic Receptors 14%
15. Apoptosis 14%
16. Hematologic Neoplasms 13%
17. T-Lymphocytes 12%
18. Receptor Protein-Tyrosine Kinases 12%
19. Bone Resorption 11%
20. Tumor Burden 11%
21. Therapeutics 11%
22. growth arrest-specific protein 6 10%
23. c-Mer Tyrosine Kinase 10%
24. Cell Proliferation 10%
25. In Vitro Techniques 10%
26. Osteogenesis 9%
27. Cell Line 9%
28. Standard of Care 8%
29. Bone Marrow 8%
30. Bortezomib 8%
31. Flow Cytometry 8%
32. Growth 7%
33. Disease Progression 7%
34. Adrenergic beta-Antagonists 6%
35. axl receptor tyrosine kinase 5%
36. Adrenergic Antagonists 5%
37. Immunotherapy 5%
38. Melphalan 5%
39. Natural Killer Cells 5%